Zobrazeno 1 - 10
of 143
pro vyhledávání: '"YUICHIRO TADA"'
Autor:
Takashi Matsuki, Daisuke Kawakita, Hideaki Takahashi, Takuro Okada, Akihiro Sakai, Yushi Ueki, Hiroshi Tsuge, Kenji Hanyu, Kaho Momiyama, Ryusuke Shodo, Mayu Yamauchi, Yukiko Asako, Hideaki Hirai, Toshitaka Nagao, Yuichiro Tada
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Although immune checkpoint inhibitors (ICIs) are effective in some patients with salivary gland carcinoma (SGC), biomarkers which predict the efficacy and prognosis of SGC patients treated with pembrolizumab have not been identified. We cond
Externí odkaz:
https://doaj.org/article/b5b7acb4c83f4a13bea2ec729ee7a8c0
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background Trastuzumab treatment for salivary gland, gastric, and breast cancer commonly causes cancer treatment-related cardiac dysfunction (CTRCD). CTRCD incidence by sex has not been well studied. Methods This retrospective cohort study i
Externí odkaz:
https://doaj.org/article/a67d4b6eac8d491f9997f4d28b176c34
Autor:
Yukiomi Kushihashi, Tatsuo Masubuchi, Isaku Okamoto, Chihiro Fushimi, Morio Yamazaki, Hisashi Asano, Reo Aoki, Shota Fujii, Yukiko Asako, Yuichiro Tada
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 471-476 (2024)
Introduction: Photoimmunotherapy (PIT) is a treatment wherein intravenous cetuximab sarotalocan sodium is administered followed by laser light irradiation. This treatment exhibits a specific antitumor effect if in tumors expressing the epidermal grow
Externí odkaz:
https://doaj.org/article/47ece69ba8be487dbda8ad1ae451692f
Autor:
Yuichiro Tada, Masaki Yamada
Publikováno v:
Physics Letters B, Vol 855, Iss , Pp 138854- (2024)
We revisit the hybrid inflation model within the framework of the Grand Unified Theory (GUT), focusing on cases where the waterfall phase transition extends over several e-foldings to dilute monopoles. Considering the stochastic effects of quantum fl
Externí odkaz:
https://doaj.org/article/208cdffdf657450fae0bc9482c882b96
Publikováno v:
Journal of High Energy Physics, Vol 2024, Iss 1, Pp 1-24 (2024)
Abstract We study the cancellation of quantum corrections on the superhorizon curvature perturbations from subhorizon physics beyond the single-clock inflation from the viewpoint of the cosmological soft theorem. As an example, we focus on the transi
Externí odkaz:
https://doaj.org/article/8cfe0b2ad128442c8940b881d290f619
Autor:
Chihiro Fushimi, Hideaki Takahashi, Daisuke Kawakita, Satoshi Kano, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Akihiro Sakai, Keisuke Yamazaki, Takuro Okada, Toyoyuki Hanazawa, Yuichiro Sato, Yorihisa Imanishi, Akira Shimizu, Takashi Matsuki, Toshitaka Nagao, Yuichiro Tada
Publikováno v:
Cancer Medicine, Vol 13, Iss 5, Pp n/a-n/a (2024)
Abstract Background Salivary duct carcinoma (SDC) is a high‐grade adenocarcinoma with a 5‐year survival rate of 40%. Although drug therapy has improved patients' prognosis, the impact of brain metastasis (BM) remains poorly understood. We aimed t
Externí odkaz:
https://doaj.org/article/15d1e28de5a0440e94de49f5d8890cef
Autor:
Shinji Kohsaka, Yuichiro Tada, Mizuo Ando, Masato Nakaguro, Yukina Shirai, Toshihide Ueno, Shinya Kojima, Hideaki Hirai, Natsuki Saigusa, Satoshi Kano, Kiyoaki Tsukahara, Takafumi Togashi, Hiroyuki Ozawa, Takahito Kondo, Kenji Okami, Hideaki Takahashi, Daisuke Kawakita, Chihiro Fushimi, Takayoshi Suzuki, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yuichiro Sato, Yorihisa Imanishi, Yoshihiro Watanabe, Akihiro Sakai, Koji Ebisumoto, Yukiko Sato, Makoto Urano, Yoshitaka Honma, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Tomotaka Shimura, Toshitaka Nagao, Hiroyuki Mano
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract Molecular targets and predictive biomarkers for prognosis in salivary duct carcinoma (SDC) have not been fully identified. We conducted comprehensive molecular profiling to discover novel biomarkers for SDC. A total of 67 SDC samples were ex
Externí odkaz:
https://doaj.org/article/55457a756c094554a6dc1105eb124504
Autor:
Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, Satoshi Kano, Yoshitaka Honma, Hideaki Hirai, Natsuki Saigusa, Kohei Akazawa, Kaori Tani, Hiroya Ojiri, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Takahito Kondo, Takafumi Togashi, Chihiro Fushimi, Tomotaka Shimura, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yorihisa Imanishi, Yoshihiro Watanabe, Kuninori Otsuka, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Mizuo Ando, Takashi Matsuki, Masato Nakaguro, Yukiko Sato, Makoto Urano, Yoshitaka Utsumi, Shinji Kohsaka, Takashi Saotome, Yuichiro Tada
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: The efficacy and safety of human epidermal growth factor receptor 2 (HER2)-targeted therapy and androgen deprivation therapy (ADT) for locally advanced or recurrent or metastatic (LA/RM) salivary duct carcinoma (SDC) have been reported in
Externí odkaz:
https://doaj.org/article/331f3b59c5064a0298c40bb36a684230
Autor:
Takashi Matsuki, Isaku Okamoto, Chihiro Fushimi, Michi Sawabe, Daisuke Kawakita, Hiroki Sato, Kiyoaki Tsukahara, Takahito Kondo, Takuro Okada, Yuichiro Tada, Kouki Miura, Go Omura, Taku Yamashita
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5015-5024 (2020)
Abstract Background There is increasing evidence that immunotherapy with nivolumab, an anti‐programmed death 1 monoclonal antibody, is effective in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). H
Externí odkaz:
https://doaj.org/article/d285393e829140849118c84620b0974a
Autor:
Natsuki Saigusa, Hideaki Hirai, Yuichiro Tada, Daisuke Kawakita, Masato Nakaguro, Kiyoaki Tsukahara, Satoshi Kano, Hiroyuki Ozawa, Takahito Kondo, Kenji Okami, Takafumi Togashi, Yukiko Sato, Makoto Urano, Manami Kajiwara, Tomotaka Shimura, Chihiro Fushimi, Akira Shimizu, Isaku Okamoto, Takuro Okada, Takayoshi Suzuki, Yorihisa Imanishi, Yoshihiro Watanabe, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Yoshitaka Honma, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Hideaki Takahashi, Mizuo Ando, Shinji Kohsaka, Takashi Matsuki, Toshitaka Nagao
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
ObjectiveSalivary duct carcinoma (SDC) is a highly aggressive and uncommon tumor arising not only de novo but also in pleomorphic adenoma. Androgen receptor (AR)- and HER2-targeted therapy have recently been introduced for SDC as promising treatment
Externí odkaz:
https://doaj.org/article/e81488f5cc0b418e810415db52f50f1f